Otsuka Holdings reports first quarter net profit increase to Y98.35 billion

4 articles · Updated · MarketWatch · Apr 28

The Japanese pharmaceutical group posted revenue of Y630.34 billion and operating profit of Y126.29 billion for the quarter ended March 31, 2026.
Net profit rose from Y85.00 billion a year earlier, with per share earnings increasing to Y186.31 under IFRS standards.
The improved results highlight Otsuka Holdings' continued growth momentum, reflecting higher sales and profitability compared to the previous year's first quarter.

With soaring Q1 profits, why does Otsuka forecast a full-year decline for 2026?

How will Otsuka's promising pipeline overcome Japan's strict government price controls?

Beyond blockbuster drugs, is Otsuka's future in smart-rings and health foods?

Is Otsuka's stock an undervalued gem or a bubble that is about to pop?

Can a billion-dollar bet on a new PTSD drug save Otsuka from its patent cliff?